Thalia S Field
Thalia S Field, MD is an expert in Neurology at Vancouver General Hospital (Canada). As of October 2026, ScienceLeadR ranks Thalia S Field in the top 1% of experts worldwide for Cerebrovascular Disorders, Embolism and Thrombosis and Brain Ischemia. Thalia S Field has authored 356 publications, the most recent in 2026, and is an investigator in 26 clinical trials, 3 of them ongoing. SLR score: 1,562 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 356
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Incidence of Dementia and Subsequent Outcomes in Patients With Heart Failure. PMID 42954690 — dementia, mortality, hospitalization, stroke, incidence, heart failure, heart, physicians, risk factors, diagnosis, outpatients, cognition, prognosis | JACC Adv | 2026 | 0 |
| Exercise and white matter hyperintensities: a randomized clinical trial. PMID 42948654 — white matter, exercise, growth, aging, brain, cerebrovascular disorders, sex | Brain Commun | 2026 | 0 |
| A Phase 2a randomized trial of once- versus twice-daily remote ischemic conditioning in vascular cognitive impairment (TRIC-VCI). PMID 42921033 — tumor necrosis factor-alpha, safety, blood, focus groups, cognitive dysfunction, cognition disorders, conditioning, psychological, ischemic preconditioning, cerebral small vessel diseases | Alzheimers Dement (N Y) | 2026 | 0 |
| Feasibility of multi-domain data acquisition in patients at risk for hypoxic-ischemic brain injury following cardiac arrest: a prospective cohort study. PMID 42787924 — brain injuries, serum, brain, multiple chronic conditions, cohort studies, biomarkers, electroencephalography, heart arrest | Resusc Plus | 2026 | 0 |
| Health Disparities, Inequalities and Inequities in Stroke Care: A Global Critical Integrative Review (1991-2024). PMID 42786611 — heart diseases, stroke, sex, social identification | J Am Heart Assoc | 2026 | 0 |
Clinical Studies 26
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| NoNO 42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy NCT06403267 — safety, ischemic stroke, stroke, powders, neuroprotective agents, neuroprotection, reperfusion, cerebral infarction, thrombectomy, ischemia, male | Phase 2 | Recruiting | 2024 |
| ACT GLOBAL THROMBOLYSIS (ACT WHEN 001) Domain Within the ACT GLOBAL Adaptive Platform Trial NCT06352632 NCT06320431 — ischemic stroke, stroke, multiple chronic conditions, body weight, tenecteplase, therapeutics, thrombectomy, direct-acting oral anticoagulants | Phase 3 | Recruiting | 2024 |
| EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE MeVO Trial) NCT05151172 — safety, blood, ischemic stroke, stroke, pharmaceutical preparations, blood pressure, fibrinolytic agents, intracranial thrombosis, coagulants, therapeutics, thrombosis, thrombectomy, blood vessels | N/A | Active not recruiting | 2022 |
LeadR Networks
Main global connection map